POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
2018 ◽
Vol 36
(26)
◽
pp. 2743-2744
◽
2021 ◽
Vol 77
(18)
◽
pp. 3298